Validation Data Gallery
|Positive WB detected in||HL-60 cells, HeLa cells, Jurkat cells|
|Positive IP detected in||HeLa cells|
|Positive IHC detected in||human kidney tissue, human liver tissue, human prostate cancer tissue, human stomach tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HeLa cells|
|Western Blot (WB)||WB : 1:500-1:3000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
18220-1-AP targets IkB Alpha in WB, IP, IHC, IF, ELISA applications and shows reactivity with human samples.
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||IkB Alpha fusion protein Ag12979|
|Full Name||nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha|
|Calculated molecular weight||36 kDa|
|Observed molecular weight||39 kDa|
|GenBank accession number||BC004983|
|Gene ID (NCBI)||4792|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA, synonyms: IKBA, MAD-3, NFKBI). NFKB1 or NFKB2 is bound to REL, RELA , or RELB to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime.
|Product Specific Protocols|
|WB protocol for IkB Alpha antibody 18220-1-AP||Download protocol|
|IHC protocol for IkB Alpha antibody 18220-1-AP||Download protocol|
|IF protocol for IkB Alpha antibody 18220-1-AP||Download protocol|
|IP protocol for IkB Alpha antibody 18220-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Activation of the NF-¿B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Front Mol Neurosci
Electroacupuncture Suppresses the NF-κB Signaling Pathway by Upregulating Cylindromatosis to Alleviate Inflammatory Injury in Cerebral Ischemia/Reperfusion Rats.
Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats.
Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression.
Cancer Biol Ther
MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X.
Eur J Pharmacol
Tubeimoside I protects against sepsis-induced cardiac dysfunction via SIRT3.